Stay updated on Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. There are no visible changes to study details or outcomes.
    Difference
    0.1%
    Check dated 2026-03-10T00:30:17.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no clinical content, eligibility criteria, results, or critical page data were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-16T15:54:51.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1. This appears to be a metadata update and does not affect core content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-09T12:19:37.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added: Show glossary option, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-26T07:35:04.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4; no page content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-19T04:40:16.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Added a Locations section listing Pennsylvania as the study site and removed the old Pennsylvania Locations entry. Updated page revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-22T00:00:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.